Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 42(16):1554–1568
Article PubMed PubMed Central Google Scholar
Adam RD, Coriu D, Jercan A et al (2021) Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail 8(4):2380–2396
Article PubMed PubMed Central Google Scholar
Mohammed SF, Mirzoyev SA, Edwards WD et al (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2:113–122
Article PubMed PubMed Central Google Scholar
Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112(13):2047–2060
Di Nora C, Livi U (2020) Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis. Curr Opin Organ Transplant 25(3):211–217
Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS et al (2011) Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 4(3):266–275
Molina EJ, Shah P, Kiernan MS et al (2021) The society of thoracic surgeons intermacs 2020 annual report. Ann Thorac Surg 111(3):778–792
Gustafsson F, Rogers JG (2017) Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail 19(5):595–602
Fukamachi K, Shiose A, Massiello A et al (2013) Preload sensitivity in cardiac assist devices. Ann Thorac Surg 95(1):373–380
Grupper A, Park SJ, Pereira NL et al (2015) Role of ventricular assist therapy for patients with heart failure and restrictive physiology: improving outcomes for a lethal disease. J Heart Lung Transplant 34(8):1042–1049
Pagani FD, Miller LW, Russell SD et al (2009) Extended mechanical circulatory support with a continuous-flowrotary left ventricular assist device. J Am Coll Cardiol 54:312–321
Bellavia D, Iacovoni A, Scardulla C et al (2017) Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail 19(7):926–946
Article CAS PubMed Google Scholar
Bodez D, Ternacle J, Guellich A et al (2016) Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid 23(3):158–167
Article CAS PubMed Google Scholar
Arvidsson S, Henein MY, Wikström G, Suhr OB, Lindqvist P (2018) Right ventricular involvement in transthyretin amyloidosis. Amyloid 25(3):160–166
Article CAS PubMed Google Scholar
Patel SR, Saeed O, Naftel D et al (2017) Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis. J Card Fail 23(12):859–867
Imamura T, Kinugawa K, Kato N et al (2014) Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 78(3):625–633
Article CAS PubMed Google Scholar
Vivo RP, Cordero-Reyes AM, Qamar U et al (2013) Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device. J Heart Lung Transplant 32(8):792–799
Topilsky Y, Oh JK, Shah DK et al (2011) Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging 4(3):211–222
Kukucka M, Stepanenko A, Potapov E et al (2011) Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant 30(1):64–69
Wan K, Sun J, Han Y et al (2018) Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis. Heart Vessels 33(2):170–179
Liu D, Hu K, Herrmann S et al (2017) Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis. Int J Cardiovasc Imaging 33(6):837–845
Article PubMed PubMed Central Google Scholar
Ghio S, Perlini S, Palladini G et al (2007) Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 9(8):808–813
Bellavia D, Pellikka PA, Al-Zahrani GB et al (2010) Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 23(6):643–652
Article PubMed PubMed Central Google Scholar
Fine NM, White JA, Jimenez-Zepeda V et al (2020) Determinants and prognostic significance of serial right heart function changes in patients with cardiac amyloidosis. Can J Cardiol 36(3):432–440
Wan K, Lin J, Guo X et al (2020) Prognostic value of right ventricular dysfunction in patients with AL amyloidosis: comparison of different techniques by cardiac magnetic resonance. J Magn Reson Imaging 52(5):1441–1448
Maleszewski JJ (2015) Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 24(6):343–350
Article CAS PubMed Google Scholar
Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M et al (2004) Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94(8):1008–1010
Article CAS PubMed Google Scholar
Binder C, Duca F, Stelzer PD et al (2019) Mechanisms of heart failure in transthyretin vs. light chain amyloidosis. Eur Heart J Cardiovasc Imaging 20(5):512–524
Cappelli F, Porciani MC, Bergesio F et al (2012) Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13:416–422
Dungu J, Whelan CJ, Gibbs SD et al (2012) Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis. J Cardiovasc Magn Reson 14:O87
Article PubMed Central Google Scholar
Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98:1442–1448
Moñivas Palomero V, Durante-Lopez A, Sanabria MT et al (2019) Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr 32(7):845-853.e1
Mehta P, Chapel DB, Goyal N et al (2019) A histopathologic schema to quantify the burden of cardiac amyloidosis: relationship with survival and echocardiographic parameters. Echocardiography 36(2):285–291
Kim D, Choi JO, Kim K, Kim SJ, Kim JS, Jeon ES (2021) Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis. ESC Heart Fail 8(6):5594–5599
Article PubMed PubMed Central Google Scholar
Nicol M, Siguret V, Vergaro G et al (2022) Thromboembolism and bleeding in systemic amyloidosis: a review. ESC Heart Fail 9(1):11–20.
Tanaka Y, Hosotani K, Fukushima M (2020) A case of amyloid light-chain amyloidosis presenting with submucosal hematoma and bleeding in the upper gastrointestinal tract. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 18:e158–e159
Sundaram S, Rathod R (2019) Gastric amyloidosis causing nonvariceal upper gastrointestinal bleeding. ACG Case Rep J 6:3–4
Kumar S, Dispenzieri A, Lacy MQ, Litzow MR, Gertz MA (2001) High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transplant 28:381–385
Article CAS PubMed Google Scholar
Tabit CE, Chen P, Kim GH, Fedson SE, Sayer G, Coplan MJ, Jeevanandam V, Uriel N, Liao JK (2016) Elevated Angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation 134:141–152
留言 (0)